ストックスクリーナーアプリを入手
2.32
2.65%
0.06
アフターアワーズ：
2.20
-0.12
-5.17%
Equillium Inc (EQ) 最新ニュース
EQ News | EQUILLIUM INC (NASDAQ:EQ) - ChartMill
Equillium to Host Virtual Investor Event to Share New - GlobeNewswire
EQ Stock Chart | EQUILLIUM INC (NASDAQ:EQ) - ChartMill
ADAR1 entities hold ~9–10% of Equillium (EQ) as of Mar 31, 2026 - Stock Titan
Decheng Capital & Xiangmin Cui report 5.73M EQ shares (EQ) - Stock Titan
Oppenheimer Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Equillium: Compliance, Operational and Market Risks Cloud Long-Term Outlook for Shareholders - TipRanks
TradingKey - TradingKey
Equillium, Inc. Stock 12‑Month Price Target Cut to $6.38, Implies 176% Upside - TradingView
Equillium (EQ) Advances Research on EQ504 for Immune Modulation - GuruFocus
Is Equillium (EQ) 2210.0% Overvalued After Q1 2026 Earnings? GF - GuruFocus
Equillium Inc. (NASDAQ:EQ) Reports Narrower Q1 Loss But Slight EPS Miss as EQ504 Study Timeline Confirmed - ChartMill
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights - The Manila Times
Equillium, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Equillium (NASDAQ: EQ) trims Q1 2026 loss, raises $35M and funds runway into 2029 - Stock Titan
Equillium (NASDAQ: EQ) trims Q1 2026 loss and extends cash runway into 2029 - Stock Titan
Number of shareholders of Equillium, Inc. – NASDAQ:EQ - TradingView
Number of shareholders of Equillium, Inc. – DUS:0FY - TradingView
Equillium Inc expected to post a loss of 4 cents a shareEarnings Preview - TradingView
EQ (Equillium) EPS beats by 35% but shares fall 1.4% as investors eye pipeline milestones over near-term losses.Trending Volume Leaders - newser.com
What separates Equillium (EQ) from the pack? (-1.38%) 2026-05-07Momentum Investing - Newser
Aberdeen Group (NASDAQ: EQ) shows 3.35M-share stake in Equillium - Stock Titan
Should you add Equillium (EQ) to your watchlist today? (Bearish Momentum) 2026-05-05High Interest Stocks - Newser
Equillium, Inc. (NASDAQ:EQ) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Equillium, Inc. Grants Inducement Stock Options to New Employees Under 2024 Inducement Plan - Quiver Quantitative
Two new Equillium hires receive options for 800,000 shares - Stock Titan
B Riley Securities initiates coverage of Equillium (EQ) with buy recommendation - MSN
Equillium (EQ) price target increased by 120.00% to 5.61 - MSN
Oppenheimer Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $7 - Moomoo
Equillium (NASDAQ:EQ) Coverage Initiated by Analysts at Oppenheimer - MarketBeat
Oppenheimer Initiates Coverage on Equillium With Outperform Rating, $7 Price Target - marketscreener.com
Oppenheimer initiates Equillium stock with Outperform on UC drug By Investing.com - Investing.com Australia
Oppenheimer initiates Equillium stock with Outperform on UC drug - Investing.com
Equillium initiated with an Outperform at Oppenheimer - TipRanks
Is It Stable or Volatile | Equillium Inc. Posts 35.3% EPS Beat, Narrower Net Loss Vs EstimatesElite Trading Signals - Cổng thông tin điện tử tỉnh Lào Cai
Roth MKM Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event - The Manila Times
EQ Reiterated by Roth Capital -- Price Target Maintained at $12 - GuruFocus
Equillium (EQ) price target increased by 10.71% to 7.90 - MSN
Roth Mkm Reiterates Buy Rating for Equillium (NASDAQ:EQ) - MarketBeat
[EFFECT] Equillium, Inc. SEC Filing - Stock Titan
Here’s what Roth Capital thinks of Equillium (EQ) stock - MSN
EQ Upgraded by B. Riley Securities -- Price Target Announced at $6.00 - GuruFocus
0.98%
0.12%
大文字化:
|
ボリューム (24 時間):